62 results  1 of 4 

1 Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
Seung Il Jung, Myung Soo Kim, Chang Wook Jeong, Cheol Kwak, Sung Kyu Hong, Seok Ho Kang, Jae Young Joung, Seung Hwan Lee, Seok Joong Yun, Tae-Hwan Kim, Sung Woo Park, Seong Soo Jeon, Minyong Kang, Ji Youl Lee, Byung Ha Chung, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim, Dong Deuk Kwon
Investig Clin Urol.2020;61(1):19-27.   Published online 2019 December 10     DOI: http://dx.doi.org/10.4111/icu.2020.61.1.19
      
2 Subclassification of pathologically organ-confined (pT2) prostate cancer does not significantly predict postoperative outcomes in Korean males
Min Ho Lee, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee
Investig Clin Urol.2020;61(1):35-41.   Published online 2019 December 2     DOI: http://dx.doi.org/10.4111/icu.2020.61.1.35
      
3 Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma
Nornazirah Azizan, Firdaus Hayati, Nur Maya Sabrina Tizen, Wirda Indah Farouk, Noraidah Masir
Investig Clin Urol.2018;59(4):232-237.   Published online 2018 June 18     DOI: http://dx.doi.org/10.4111/icu.2018.59.4.232
      
4 US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses
Glen Gejerman, Patrick Ciccone, Martin Goldstein, Vincent Lanteri, Burton Schlecker, John Sanzone, Michael Esposito, Sergey Rome, Michael Ciccone, Eric Margolis, Robert Simon, Yijun Guo, Sri-Ram Pentakota, Hossein Sadhegi-Nejad
Investig Clin Urol.2017;58(6):423-428.   Published online 2017 November 2     DOI: http://dx.doi.org/10.4111/icu.2017.58.6.423
      
5 Overdiagnosis in health care: impact of cancer screening
Hyeong Sik Ahn
J Korean Med Assoc.2017;60(4):323-329.   Published online 2017 April 30     DOI: http://dx.doi.org/10.5124/jkma.2017.60.4.323
      
6 Early dutasteride monotherapy in men with detectable serum prostate-specific antigen levels following radical prostatectomy: A prospective trial
Yu Seob Shin, Jea Whan Lee, Myung Ki Kim, Young Beom Jeong, Seung Chol Park
Investig Clin Urol.2017;58(2):98-102.   Published online 2017 February 15     DOI: http://dx.doi.org/10.4111/icu.2017.58.2.98
      
7 Predicting biochemical recurrence in patients with high-risk prostate cancer using the apparent diffusion coefficient of magnetic resonance imaging
Min Young Yoon, Juhyun Park, Jeong Yeon Cho, Chang Wook Jeong, Ja Hyeon Ku, Hyeon Hoe Kim, Cheol Kwak
Investig Clin Urol.2017;58(1):12-19.   Published online 2017 January 9     DOI: http://dx.doi.org/10.4111/icu.2017.58.1.12
      
8 Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy
Roger Li, Firas G. Petros, Janet B. Kukreja, Stephen B. Williams, John W. Davis
Investig Clin Urol.2016;57(Suppl 2):S155-S164.   Published online 2016 December 8     DOI: http://dx.doi.org/10.4111/icu.2016.57.S2.S155
      
9 Standardized 4-step technique of bladder neck dissection during robot-assisted radical prostatectomy
Mansour Alnazari, Marc Zanaty, Emad Rajih, Assaad El-Hakim, Kevin C. Zorn
Investig Clin Urol.2016;57(Suppl 2):S165-S171.   Published online 2016 December 8     DOI: http://dx.doi.org/10.4111/icu.2016.57.S2.S165
      
10 Nerve-sparing techniques and results in robot-assisted radical prostatectomy
Hasan Hüseyin Tavukçu, Omer Aytac, Fatih Atug
Investig Clin Urol.2016;57(Suppl 2):S172-S184.   Published online 2016 December 8     DOI: http://dx.doi.org/10.4111/icu.2016.57.S2.S172
      
11 Urethral strictures after radiation therapy for prostate cancer
Felix Moltzahn, Alan Dal Pra, Marc Furrer, George Thalmann, Martin Spahn
Investig Clin Urol.2016;57(5):309-315.   Published online 2016 September 7     DOI: http://dx.doi.org/10.4111/icu.2016.57.5.309
      
12 Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
Peter Ka-Fung Chiu, Jeremy Yuen-Chun Teoh, Wai-Man Lee, Chi-Hang Yee, Eddie Shu-Yin Chan, See-Ming Hou, Chi-Fai Ng
Investig Clin Urol.2016;57(5):336-342.   Published online 2016 August 31     DOI: http://dx.doi.org/10.4111/icu.2016.57.5.336
      
13 Therapeutic efficacy of nanomedicines for prostate cancer: An update
Vinoth-Kumar Lakshmanan
Investig Clin Urol.2016;57(1):21-29.   Published online 2016 January 11     DOI: http://dx.doi.org/10.4111/icu.2016.57.1.21
      
14 Multiple cores of high grade prostatic intraepithelial neoplasia and any core of atypia on first biopsy are significant predictor for cancer detection at a repeat biopsy
Tae Sun Kim, Kwang Jin Ko, Seung Jea Shin, Hyun Soo Ryoo, Wan Song, Hyun Hwan Sung, Deok Hyun Han, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Kyu Sung Lee, Sung Won Lee, Hyun Moo Lee, Han Yong Choi, Hwang Gyun Jeon
Korean J Urol.2015;56(12):796-802.   Published online 2015 November 26     DOI: http://dx.doi.org/10.4111/kju.2015.56.12.796
      
15 Discordance between location of positive cores in biopsy and location of positive surgical margin following radical prostatectomy
Ji Won Kim, Hyoung Keun Park, Hyeong Gon Kim, Dong Yeub Ham, Sung Hyun Paick, Yong Soo Lho, Woo Suk Choi
Korean J Urol.2015;56(10):710-716.   Published online 2015 October 6     DOI: http://dx.doi.org/10.4111/kju.2015.56.10.710
      
16 Effect of curcumin on the interaction between androgen receptor and Wnt/β-catenin in LNCaP xenografts
Jeong Hee Hong, Gilho Lee, Han Yong Choi
Korean J Urol.2015;56(9):656-665.   Published online 2015 August 31     DOI: http://dx.doi.org/10.4111/kju.2015.56.9.656
      
17 Clinical effect of abiraterone acetate in Korean patients with metastatic castration-resistant prostate cancer according to duration of androgen deprivation therapy
Ki Bom Kim, Jung Ki Jo, Soyeon Ahn, Sangchul Lee, Seong Jin Jeong, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee
Korean J Urol.2015;56(8):580-586.   Published online 2015 August 6     DOI: http://dx.doi.org/10.4111/kju.2015.56.8.580
      
18 Stereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma
Bae-Kwon Jeong, Hojin Jeong, In Bong Ha, Hoon Sik Choi, Sung Chul Kam, Jeong Seok Hwa, Jae Seog Hyun, Ky Hyun Chung, See Min Choi, Ki Mun Kang
J Korean Med Sci.2015;30(6):710-715.   Published online 2015 May 13     DOI: http://dx.doi.org/10.3346/jkms.2015.30.6.710
      
19 Prevalence and clinical significance of incidental 18F-fluoro-2-deoxyglucose uptake in prostate
Taekmin Kwon, In Gab Jeong, Dalsan You, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim
Korean J Urol.2015;56(4):288-294.   Published online 2015 March 20     DOI: http://dx.doi.org/10.4111/kju.2015.56.4.288
      
20 Clinicopathological Features of Prostate Ductal Carcinoma: Matching Analysis and Comparison with Prostate Acinar Carcinoma
Aram Kim, Taekmin Kwon, Dalsan You, In Gab Jeong, Heounjeong Go, Yong Mee Cho, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim
J Korean Med Sci.2015;30(4):385-389.   Published online 2015 March 19     DOI: http://dx.doi.org/10.3346/jkms.2015.30.4.385
      

 1 of 4